Literature DB >> 15902438

Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study.

Hein J Verberne1, Christel Feenstra, W Matthijs de Jong, G Aernout Somsen, Berthe L F van Eck-Smit, Ellinor Busemann Sokole.   

Abstract

PURPOSE: (123)I presents imaging problems owing to high-energy photon emission. We investigated the influence of collimators on (123)I-MIBG heart/mediastinum ratios (H/M ratios). Secondly, we assessed the influence on H/M ratios of different activity concentrations, simulating clinical conditions. Thirdly, the value of scatter correction was assessed.
METHODS: The AGATE cardiac phantom was filled with (123)I in three sequential conditions: A, heart and mediastinal activity; B, adding lung activity; and C, adding liver activity (protocol I). In protocol II, myocardium and liver were filled with different activities ranging from low to high. For each condition, static anterior planar and single-photon emission computed tomography studies were acquired on a Siemens e.cam (SI) and a General Electric Millennium VG (GE) system, using low-energy high-resolution and medium-energy (ME) collimators for protocol I and only ME collimators for protocol II . For the SI camera, a triple energy window (TEW) scatter correction was applied.
RESULTS: Planar H/M ratios were influenced by scatter and septal penetration from increasing amounts of liver activity. These effects were less pronounced for ME collimators. Although the TEW scatter correction increased ratios overall, TEW correction did not improve the relative differences between the ratios. TEW correction therefore does not add any benefit to obtain an accurate reflection of myocardial activity concentrations.
CONCLUSION: For straightforward implementation of semi-quantitative (123)I-MIBG myocardial studies, we recommend the use of ME collimators without scatter correction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902438     DOI: 10.1007/s00259-005-1810-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  20 in total

1.  Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method.

Authors:  K Saito; K Takeda; S Okamoto; R Okamoto; K Makino; Y Tameda; Y Nomura; H Maeda; T Ichihara; T Nakano
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

Review 2.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

3.  Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.

Authors:  J Yamazaki; H Muto; T Kabano; S Yamashina; S Nanjo; A Inoue
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

4.  Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.

Authors:  Myron C Gerson; Laura L Craft; Nancy McGuire; Damodhar P Suresh; William T Abraham; Lynne E Wagoner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

5.  A realistic 3-D gated cardiac phantom for quality control of gated myocardial perfusion SPET: the Amsterdam gated (AGATE) cardiac phantom.

Authors:  Jacco J N Visser; Ellinor Busemann Sokole; Hein J Verberne; Jan B A Habraken; Huybert J F van de Stadt; Joris E N Jaspers; Morgan Shehata; Paul M Heeman; Berthe L F van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

6.  Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study.

Authors:  H Ogita; T Shimonagata; M Fukunami; K Kumagai; T Yamada; Y Asano; A Hirata; M Asai; H Kusuoka; M Hori; N Hoki
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

7.  Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT.

Authors:  T Ichihara; K Ogawa; N Motomura; A Kubo; S Hashimoto
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

Review 8.  Scatter correction in scintigraphy: the state of the art.

Authors:  I Buvat; H Benali; A Todd-Pokropek; R Di Paola
Journal:  Eur J Nucl Med       Date:  1994-07

9.  Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.

Authors:  G A Somsen; B van Vlies; P A de Milliano; J J Borm; E A van Royen; E Endert; K I Lie
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

10.  Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake.

Authors:  Yusuke Inoue; Akira Suzuki; Ichiro Shirouzu; Toru Machida; Yasunori Yoshizawa; Fumihide Akita; Satoshi Ohnishi; Kohki Yoshikawa; Kuni Ohtomo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

View more
  42 in total

1.  Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.

Authors:  Kenichi Nakajima; Koichi Okuda; Shinro Matsuo; Mitsuhiro Yoshita; Junichi Taki; Masahito Yamada; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-19       Impact factor: 9.236

2.  How to use myocardial 123I-MIBG scintigraphy in chronic heart failure.

Authors:  Denis Agostini; Ignasi Carrio; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 9.236

3.  Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease.

Authors:  Africa Muxí; Pilar Paredes; Ignacio Navales; Francesc Valldeoriola; Carles Gaig; Francisco Lomeña; Andres de la Cerda; Oriol Solà; Beatriz Domenech; Eduardo Tolosa; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-04       Impact factor: 9.236

4.  First assessment of simultaneous dual isotope (123I/99mTc) cardiac SPECT on two different CZT cameras: A phantom study.

Authors:  Tanguy Blaire; Alban Bailliez; Fayçal Ben Bouallegue; Dimitri Bellevre; Denis Agostini; Alain Manrique
Journal:  J Nucl Cardiol       Date:  2017-03-08       Impact factor: 5.952

5.  123I-mIBG and the phantom tollbooth.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2017-03-13       Impact factor: 5.952

Review 6.  Evaluating presynaptic and postsynaptic innervation in heart failure.

Authors:  Grace P Chen; James H Caldwell
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

7.  Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Hui-Ling Li; Jumpei Suyama; Akira Shinozuka; Takehiko Gokan; Mitsuharu Kawamura; Taku Asano; Yuji Hamazaki; Kaoru Tanno; Youichi Kobayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

8.  Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.

Authors:  Shinro Matsuo; Kenichi Nakajima; Koichi Okuda; Masaya Kawano; Takehiro Ishikawa; Tetsuo Hosoya; Junichi Taki; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-07       Impact factor: 9.236

9.  Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout.

Authors:  Hein J Verberne; G Aernout Somsen; Pavol Povinec; Berthe L F van Eck-Smit; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

Review 10.  Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function.

Authors:  Kenichi Nakajima
Journal:  Ann Nucl Med       Date:  2010-01-29       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.